TransMedics Group annual gross margin
2018
2019
2020
2021
2022
2023
2024
2025
TransMedics Group's gross margin was 59.92% for fiscal 2025.
View full TransMedics Group company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 59.92% | +0.56 pp |
| 2024 | 2024-12-31 | 59.36% | −4.42 pp |
| 2023 | 2023-12-31 | 63.77% | −6.07 pp |
| 2022 | 2022-12-31 | 69.84% | +2.42 pp |
| 2021 | 2021-12-31 | 67.42% | +8.75 pp |
| 2020 | 2020-12-31 | 58.66% | +5.02 pp |
| 2019 | 2019-12-28 | 53.64% | +14.52 pp |
| 2018 | 2018-12-29 | 39.12% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 59.59% | −1.78 pp |
| Q1 2026 | 2026-03-31 | 58.16% | −3.31 pp |
| Q4 2025 | 2025-12-31 | 58.11% | −1.10 pp |
| Q3 2025 | 2025-09-30 | 58.80% | +2.86 pp |
| Q2 2025 | 2025-06-30 | 61.38% | +0.78 pp |
| Q1 2025 | 2025-03-31 | 61.47% | −0.45 pp |
| Q4 2024 | 2024-12-31 | 59.21% | +0.17 pp |
| Q3 2024 | 2024-09-30 | 55.94% | −5.27 pp |
| Q2 2024 | 2024-06-30 | 60.59% | −9.44 pp |
| Q1 2024 | 2024-03-31 | 61.91% | −7.31 pp |
| Q4 2023 | 2023-12-31 | 59.04% | −4.17 pp |
| Q3 2023 | 2023-09-30 | 61.21% | −13.33 pp |
| Q2 2023 | 2023-06-30 | 70.03% | +0.10 pp |
| Q1 2023 | 2023-03-31 | 69.23% | −7.00 pp |
| Q4 2022 | 2022-12-31 | 63.21% | −9.05 pp |
| Q3 2022 | 2022-09-30 | 74.54% | +4.84 pp |
| Q2 2022 | 2022-06-30 | 69.93% | +5.44 pp |
| Q1 2022 | 2022-03-31 | 76.22% | +13.23 pp |
| Q4 2021 | 2021-12-31 | 72.26% | +13.50 pp |
| Q3 2021 | 2021-09-30 | 69.70% | +6.51 pp |
| Q2 2021 | 2021-06-30 | 64.49% | +15.82 pp |
| Q1 2021 | 2021-03-31 | 63.00% | +4.04 pp |
| Q4 2020 | 2020-12-31 | 58.76% | +0.87 pp |
| Q3 2020 | 2020-09-30 | 63.19% | +9.66 pp |
| Q2 2020 | 2020-06-30 | 48.66% | −4.97 pp |
| Q1 2020 | 2020-03-31 | 58.96% | +10.32 pp |
| Q4 2019 | 2019-12-28 | 57.88% | +19.27 pp |
| Q3 2019 | 2019-09-28 | 53.53% | +8.69 pp |
| Q2 2019 | 2019-06-29 | 53.63% | +17.51 pp |
| Q1 2019 · Mar 30 | 2019-03-30 | 48.64% | +15.11 pp |
| Q4 2018 | 2018-12-29 | 38.61% | — |
| Q3 2018 | 2018-09-29 | 44.84% | — |
| Q2 2018 | 2018-06-30 | 36.12% | — |
| Q1 2018 | 2018-03-31 | 33.53% | — |
Over the last five reported fiscal years, TransMedics Group's gross margin increased from 58.66% to 59.92%, a change of +1.25 percentage points. The latest reported quarter, Q2 2026, shows 59.59%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TransMedics Group filings at SEC.gov ↗